Bulletin
Investor Alert

New York Markets Open in:

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Jul 13, 2020, 8:47 a.m.

/zigman2/quotes/209129655/composite

$

8.06

Change

+0.05 +0.62%

Volume

Volume 81,023

Real time quotes

/zigman2/quotes/209129655/composite

Previous close

$ 8.01

$ 8.01

Change

+0.60 +8.10%

Day low

Day high

$7.42

$8.10

Open

52 week low

52 week high

$2.43

$46.25

Open

Insider Actions for Tilray Inc. Cl 2

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/05/2020 Edward Wood Pastorius
Chief Revenue Officer
7,822   Derivative/Non-derivative trans. at $3.13 per share. 24,482
07/05/2020 Edward Wood Pastorius
Chief Revenue Officer
4,693   Derivative/Non-derivative trans. at $5.28 per share. 24,779
07/01/2020 Brendan Kennedy
President and CEO; Director
18,446   Derivative/Non-derivative trans. at $7.01 per share. 129,306
07/01/2020 Edward Wood Pastorius
Chief Revenue Officer
1,812   Derivative/Non-derivative trans. at $7.01 per share. 12,702
07/01/2020 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2020 Michael Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2020 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
06/18/2020 Andrew Pucher
Chief Corporate Dev Officer
4,009   Derivative/Non-derivative trans. at $0 per share. 0
06/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
06/17/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $8.04 per share. 937,994
06/16/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $8.34 per share. 972,994
06/05/2020 Michael Shtender-Auerbach
Director
10,475   0
06/05/2020 Michael Shtender-Auerbach
Director
210,710   0
06/05/2020 Michael Shtender-Auerbach
Director
57,159   0
06/05/2020 Michael Shtender-Auerbach
Director
538,706   0
06/01/2020 Maryscott Greenwood
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2020 Rebekah Dopp
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2020 Christine Thompson St. Clare
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Michael Shtender-Auerbach
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Maryscott Greenwood
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Rebekah Dopp
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Christine Thompson St. Clare
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Michael Shtender-Auerbach
Director
125,580   Disposition at $7.38 per share. 926,780
05/01/2020 Michael Shtender-Auerbach
Director
95,131   Disposition at $7.38 per share. 702,066
05/01/2020 Michael Shtender-Auerbach
Director
18,290   Derivative/Non-derivative trans. at $0.19 per share. 3,475
05/01/2020 Michael Shtender-Auerbach
Director
107,290   Derivative/Non-derivative trans. at $0.19 per share. 20,385
04/06/2020 Michael Shtender-Auerbach
Director
1,069   0
04/06/2020 Michael Shtender-Auerbach
Director
6,822   0
04/06/2020 Michael Shtender-Auerbach
Director
425,235   0
04/06/2020 Michael Shtender-Auerbach
Director
166,326   0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
18 Purchases
8 Sales
515,296
1,017,016
Last 6 months
28 Purchases
13 Sales
715,085
1,736,064
Last 12 months
48 Purchases
25 Sales
4,650,883
2,092,320

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Mr. Cuba Flowers
Chief Information Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Ms. Kristina Adamski
Executive Vice President-Corporate Affairs
Mr. John Andonoff
SVP-Global Medical Sales Development
Mr. Edward Wood Pastorius
Chief Revenue Officer
Mr. Andrew Pucher
Chief Corporate Development Officer
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Mr. Mark Castaneda
Head-Strategic Business Development
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.